Business Context and Reporting Period
Company: Agape ATP Corp (ATPC)
Filing Type: Form 8-K (Current Report)
Date of Report: September 25, 2024
Reporting Period: Event date September 25, 2024; Report signed September 30, 2024.
Business Context: The Company, incorporated in Nevada with principal offices in Kuala Lumpur, Malaysia, is listed on the NASDAQ Capital Market. This filing reports the entry into a material definitive agreement.
Key Financial Metrics
This Form 8-K filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing is strictly an event report regarding a new corporate agreement.
Material Changes
Item 1.01 - Entry into a Material Definitive Agreement:
- Counterparty: Formedic Technologies Sdn Bhd ("Formedic").
- Agreement Date: September 25, 2024.
- Project Title: "AGAPE ATP Corporation To Introduce LEGA with Formedic."
- Announcement: A press release regarding this agreement was issued on September 30, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the Collaboration Agreement but does not provide specific financial projections, revenue guidance, or detailed operational outlook related to the project.
Risks and Contingencies: The filing text does not explicitly list risks, contingencies, or unusual items associated with the agreement beyond the standard disclosure of the agreement's existence.
Investor Verification Checklist
- Review the full text of the Collaboration Agreement (Exhibit 99.1) to understand specific obligations, payment terms, and termination clauses.
- Read the Press Release dated September 30, 2024 (Exhibit 99.2) for additional context on the "LEGA" project.
- Verify the financial health and reputation of Formedic Technologies Sdn Bhd as a new strategic partner.
- Monitor future filings for updates on the project's progress or any financial impact resulting from the collaboration.